Holen Sie sich die Stockscreener-App
1.30
0.77%
0.00
Handel nachbörslich:
1.30
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CTXR?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$1.30
Offen:
$1.26
24-Stunden-Volumen:
376.07K
Relative Volume:
0.84
Marktkapitalisierung:
$22.12M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-39.14M
KGV:
-0.2178
EPS:
-5.97
Netto-Cashflow:
$-28.20M
1W Leistung:
-6.43%
1M Leistung:
+8.26%
6M Leistung:
+32.35%
1J Leistung:
-85.26%
1-Tages-Spanne:
$1.23
$1.34
1-Wochen-Bereich:
$1.22
$1.37
52-Wochen-Spanne:
$0.65
$12.84
Citius Pharmaceuticals Inc Stock (CTXR) Company Profile
Firmenname
Citius Pharmaceuticals Inc
Sektor
Branche
Telefon
(908) 967-6676
Adresse
11 COMMERCE DRIVE, CRANFORD, NJ
Vergleichen Sie CTXR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CTXR
Citius Pharmaceuticals Inc
|
1.30 | 22.12M | 0 | -39.14M | -28.20M | -5.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Citius Pharmaceuticals Inc Stock (CTXR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-30 | Hochstufung | D. Boral Capital | Hold → Buy |
| 2021-11-30 | Eingeleitet | Maxim Group | Buy |
Citius Pharmaceuticals Inc Aktie (CTXR) Neueste Nachrichten
Can Citius Pharmaceuticals Inc. (47N0) stock sustain breakout momentumWeekly Investment Recap & Weekly High Conviction Ideas - newser.com
How currency fluctuations impact Citius Pharmaceuticals Inc. stockJuly 2025 Summary & Expert Approved Trade Ideas - newser.com
Has Citius Pharmaceuticals Inc. found a price floorRisk Management & Precise Entry and Exit Recommendations - newser.com
Should you wait for a breakout in Citius Pharmaceuticals Inc.July 2025 Patterns & Verified Chart Pattern Trade Signals - newser.com
What earnings revisions data tells us about Citius Pharmaceuticals Inc.Global Markets & Smart Swing Trading Alerts - newser.com
Why Citius Pharmaceuticals Inc. stock could outperform in 2025Dividend Hike & Daily Entry Point Trade Alerts - newser.com
Is Citius Pharmaceuticals Inc. (47N0) stock considered safe havenRate Cut & Long-Term Capital Growth Strategies - newser.com
Is Citius Pharmaceuticals Inc. stock positioned for long term growth2025 Sector Review & Safe Entry Zone Tips - newser.com
Short interest data insights for Citius Pharmaceuticals Inc.July 2025 Rallies & Long Hold Capital Preservation Plans - newser.com
Forecasting Citius Pharmaceuticals Inc. price range with options dataJobs Report & Weekly Consistent Profit Watchlists - newser.com
Is Citius Pharmaceuticals Inc. still worth holding after the dipJuly 2025 Retail & Risk Managed Investment Signals - newser.com
Citius in talks over Lymphir access in global markets - The Pharma Letter
Is Citius Pharmaceuticals Inc 47N0 a good long term investmentEarnings Growth Projections & High Return Capital Strategies - earlytimes.in
Citius Oncology Establishes International Access to LYMPHIR™ via Named Patient Programs in Southern Europe - Stock Titan
Published on: 2025-10-06 05:51:11 - newser.com
How strong dollar benefits Citius Pharmaceuticals Inc. (47N0) stock2025 Pullback Review & Expert Approved Momentum Ideas - newser.com
Will Citius Pharmaceuticals Inc. (47N0) stock sustain bullish trend into 2025July 2025 Intraday Action & High Yield Stock Recommendations - newser.com
Can Citius Pharmaceuticals Inc. stock double in next 5 yearsJuly 2025 Outlook & Comprehensive Market Scan Reports - newser.com
How Citius Pharmaceuticals Inc. (47N0) stock reacts to Fed tighteningTrade Volume Summary & Precise Buy Zone Identification - newser.com
Why Citius Pharmaceuticals Inc. (47N0) stock benefits from AI revolutionTrade Analysis Report & Low Drawdown Trading Strategies - newser.com
Detecting price anomalies in Citius Pharmaceuticals Inc. with AITrade Risk Assessment & Weekly High Momentum Picks - newser.com
Will Citius Pharmaceuticals Inc. (47N0) stock deliver compounding returnsWeekly Profit Report & Expert Curated Trade Setup Alerts - newser.com
Strategies to average down on Citius Pharmaceuticals Inc.July 2025 Market Mood & Reliable Entry Point Alerts - newser.com
Is Citius Pharmaceuticals Inc. (47N0) stock a buy before earnings resultsJuly 2025 PreEarnings & Intraday High Probability Alerts - newser.com
How to build a dashboard for Citius Pharmaceuticals Inc. stock2025 Analyst Calls & Real-Time Chart Breakout Alerts - newser.com
How to use a screener to detect Citius Pharmaceuticals Inc. breakoutsForecast Cut & Free Technical Pattern Based Buy Signals - newser.com
Is Citius Pharmaceuticals Inc. (47N0) stock undervalued at current priceForecast Cut & Free Technical Pattern Based Buy Signals - newser.com
Finanzdaten der Citius Pharmaceuticals Inc-Aktie (CTXR)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):